Search Results - Maag, Charlotte

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Core Glycosylation of Collagen Is Initiated by Two β(1-O)Galactosyltransferases

    Core Glycosylation of Collagen Is Initiated by Two β(1-O)Galactosyltransferases by Schegg, Belinda, Hülsmeier, Andreas J., Rutschmann, Christoph, Maag, Charlotte, Hennet, Thierry

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation

    Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation by Paesold-Burda, Patricie, Maag, Charlotte, Troxler, Heinz, Foulquier, François, Kleinert, Peter, Schnabel, Siegrun, Baumgartner, Matthias, Hennet, Thierry

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Fibrotic response in fibroblasts from congenital disorders of glycosylation

    Fibrotic response in fibroblasts from congenital disorders of glycosylation by Lecca, M. Rita, Maag, Charlotte, Berger, Eric G., Hennet, Thierry

    Request full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line

    The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line by Baumann Kubetzko, Florian B., di Paolo, Claudio, Maag, Charlotte, Meier, Roland, Schäfer, Beat W., Betts, David R., Stahel, Rolf A., Himmelmann, Andreas

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Deficiency in COGS causes a moderate form of congenital disorders of glycosylation

    Deficiency in COGS causes a moderate form of congenital disorders of glycosylation by PAESOLD-BURDAL, Patricie, MAAG, Charlotte, TROXLER, Heinz, FOULQUIER, François, KLEINERT, Peter, SCHNABEL, Siegrun, BAUMGARTNER, Matthias, HENNET, Thierry

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Multi-Omics Profiling of JMML HSPCs Reveals Onco-Fetal Reprogramming and Identifies Novel Prognostic Biomarkers and Therapeutic Targets in High-Risk JMML

    Multi-Omics Profiling of JMML HSPCs Reveals Onco-Fetal Reprogramming and Identifies Novel Prognostic Biomarkers and Therapeutic Targets in High-Risk JMML by Hartmann, Mark, Hai, Ling, Hey, Joschka, Schönung, Maximilian, Maurer, Valentin, Rajak, Jovana, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul-Habib, Lebrecht, Dirk, Bernt, Kathrin M., Roelz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Stegle, Oliver, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan-Philipp, Buske, Christian, Fröhling, Stefan, Plass, Christoph, Niemeyer, Charlotte M., Flotho, Christian, Bonder, Marc Jan, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT

    ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Hartmann, Mark, Schönung, Maximilian, Rajak, Jovana, Hey, Joschka, Maurer, Valentin, Hai, Ling, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul-Habib, Lebrecht, Dirk, Bernt, Katrin M., Roelz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan-Philipp, Buske, Christian, Milsom, Michael D., Fröhling, Stefan, Bonder, Marc-Jan, Niemeyer, Charlotte, Flotho, Christian, Plass, Christoph, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    S206: ONCO‐FETAL REPROGRAMMING DRIVES HIGH‐RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI‐CD52 TREATMENT

    S206: ONCO‐FETAL REPROGRAMMING DRIVES HIGH‐RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI‐CD52 TREATMENT by Hartmann, Mark, Schönung, Maximilian, Rajak, Jovana, Hey, Joschka, Maurer, Valentin, Hai, Ling, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul‐Habib, Lebrecht, Dirk, Bernt, Kathrin, Rölz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan‐Philipp, Buske, Christian, Milsom, Michael, Fröhling, Stefan, Bonder, Marc‐Jan, Plass, Christoph, Niemeyer, Charlotte, Flotho, Christian, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT

    S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Hartmann, Mark, Schönung, Maximilian, Rajak, Jovana, Hey, Joschka, Maurer, Valentin, Hai, Ling, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul-Habib, Lebrecht, Dirk, Bernt, Kathrin, Rölz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan-Philipp, Buske, Christian, Milsom, Michael, Fröhling, Stefan, Bonder, Marc-Jan, Plass, Christoph, Niemeyer, Charlotte, Flotho, Christian, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: